Advertisement

Topics

Aurora Capital Group Company Profile

16:13 EDT 19th June 2018 | BioPortfolio


News Articles [1305 Associated News Articles listed on BioPortfolio]

Aurora Stock: What to Expect from the Aurora-CanniMed Ceasefire

Here's Why Aurora Stock May Survive the Volatility A simple case of acquisition has turned two marijuana companies-Aurora Cannabis Inc. (TSE: ACB), (OCTMKTS: ACBFF) and CanniMed Therapeutics Inc. (...

Aurora Stock Still Strong Following Aurora-CanniMed Deal

Aurora Cannabis Inc (OTCMKTS: ACBFF), (TSE: ACB) is one of the hottest marijuana companies on the market, and for good reason. The company has seen massive growth over the past year and has vaulted...

TCR2 closes $125mm Series B round

TCR2 Therapeutics Inc. (immuno-oncology) raised $125mm through its Series B round. Curative Ventures and 6 Dimensions Capital co-led and were joined by additional new investors Redmile Group, ArrowMar...

M&As this week: Intermediate Capital Group, Novartis

Intermediate Capital Group has completed the acquisition of SuanFarma from ProA Capital, a private equity firm based in Spain. Based...Read More... The post M&As this week: Intermediate Capital G...

CT Green Bank Now Accepts Aurora Solar's Remote Shade Reports for Rebate Approval

With this announcement, Aurora becomes the industry's most validated and widely accepted solar design software. The results of Aurora's web-based software are accurate and Read more...

Aurora Cannabis: So langsam sollte ein Ausbruch folgen!

Lieber Leser, die Aktie von Aurora Cannabis verliert weiter an Boden. Auch wenn die Cannabis Branche sich weitestgehend von der schwachen Phase zu Jahresbeginn erholt hat, kann Aurora Cannabis davo...

Is Aurora Cannabis Still a Stock to Buy in 2018?

Aurora Cannabis and its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Reg...

Aurora Cannabis Exports Dried Cannabis Flower and Oils to Australia for Novel Nose-to-Brain Drug Delivery Research by PreveCeutical

Edmonton, Alberta and Vancouver, British Columbia--(Newsfile Corp. - March 13, 2018) - Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (FSE: 21P) ("Aurora") and PreveCeutical Medical Inc. (CSE: PREV...

PubMed Articles [1969 Associated PubMed Articles listed on BioPortfolio]

Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition.

Twenty five novel chemical analogs of the previously reported Aurora kinase inhibitor BPR1K653 (1-(4-(2-((5-chloro-6-phenylfuro[2,3-d]pyrimidin-4-yl)amino)ethyl)phenyl)-3-(2-((dimethylamino)methyl)phe...

The EGF/hnRNP Q1 axis is involved in tumorigenesis via the regulation of cell cycle-related genes.

Heterogeneous nuclear ribonucleoprotein (hnRNP) Q1, an RNA-binding protein, has been implicated in many post-transcriptional processes, including RNA metabolism and mRNA splicing and translation. Howe...

Community social capital and inequality in depressive symptoms among older Japanese adults: A multilevel study.

Although studies have suggested that community social capital contributes to narrow income-based inequality in depression, the impacts may depend on its components. Our multilevel cross-sectional anal...

Identification of Novel Aurora Kinase A (AURKA) Inhibitors via Hierarchical Ligand-Based Virtual Screening.

Aurora kinases are essential for cell mitosis, amplified and overexpressed in various human malignancies. Therefore, Aurora kinases have been promising targets for anticancer therapies, which has prom...

Social capital and Internet use in an age-comparative perspective with a focus on later life.

Older adults (aged 65+) are still less likely to adopt the Internet when compared to other age groups, although their usage is increasing. To explore the societal effects of Internet usage, scholars h...

Clinical Trials [3760 Associated Clinical Trials listed on BioPortfolio]

A Two-Phase Clinical Study of the Minerva AURORA Ablation System

The primary objective of this study is to evaluate the use of the Aurora Ablation System in reducing menstrual blood loss at 12 months post-treatment. The occurrence of adverse events wil...

Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

RATIONALE: Aurora A kinase inhibitor MLN8237 and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I/II trial is s...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer

The purpose of this trial is to study an investigational drug in patients with recurrent or non-responsive solid tumors, or cancers for which standard therapy does not exist.

Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors

RATIONALE: Aurora B/C kinase inhibitor GSK1070916A (GSK1070916A) may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is ...

Companies [2697 Associated Companies listed on BioPortfolio]

The Aurora Funds, Inc.

The Aurora Funds is a family of venture capital funds committed to providing resources to help early stage healthcare and information technology companies reach their full potential. Aurora’s invest...

Aurora Capital Group

Aurora Cannabis Inc.

Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes ...

Aurora Biofuels

Aurora Biofuels manufactures fuel from optimized algae in a patented production process. Leading technologists at Aurora Biofuels have engineered a cost-competitive and scalable method for fuel gene...

Aurora Algae

Aurora Algae is a producer of high-performance, premium algae-based products for the pharmaceutical, nutrition, aquaculture and fuels markets. The company has developed the indust...

More Information about "Aurora Capital Group" on BioPortfolio

We have published hundreds of Aurora Capital Group news stories on BioPortfolio along with dozens of Aurora Capital Group Clinical Trials and PubMed Articles about Aurora Capital Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aurora Capital Group Companies in our database. You can also find out about relevant Aurora Capital Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record